PDS Biotechnology (PDSB) Price/OCF Ratio: History & Chart

PDS Biotechnology Corporation(PDSB)

Biotechnology · Princeton, NJ

$0.21-0.01 (-3.21%)

At close: Aug 28, 2026, 4:00 PM ET

About PDS Biotechnology Corporation

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.

Princeton, NJ

21 employees

www.pdsbiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Frank K. Bedu-Addo

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
PDS Biotechnology Corporation (PDSB)	$11.79M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$438.82M	N/A	N/A	N/A	N/A
NRC Health (NRC)vs ›	$492.43M	16.30	15.13	16.71	19.93
Teladoc Health, Inc. (TDOC)vs ›	$1.18B	4.48	4.28	5.90	12.64
DENTSPLY SIRONA Inc. (XRAY)vs ›	$2.23B	6.99	9.53	11.53	12.66
TransMedics Group, Inc. (TMDX)vs ›	$3.06B	24.67	25.99	67.50	67.50
Doximity, Inc. (DOCS)vs ›	$5.00B	16.68	24.25	34.48	48.47
Merit Medical Systems, Inc. (MMSI)vs ›	$5.40B	19.16	17.20	25.96	27.67
Hims & Hers Health, Inc. (HIMS)vs ›	$6.43B	25.05	28.20	36.75	93.81
Chemed Corporation (CHE)vs ›	$6.84B	18.02	15.04	21.48	22.84

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

PDS Biotechnology Corporation (PDSB)

$11.79M

N/A

Shoulder Innovations, Inc. (SI)vs ›

$438.82M

N/A

NRC Health (NRC)vs ›

$492.43M

16.30

15.13

16.71

19.93

Teladoc Health, Inc. (TDOC)vs ›

$1.18B

4.48

4.28

5.90

12.64

DENTSPLY SIRONA Inc. (XRAY)vs ›

$2.23B

6.99

9.53

11.53

12.66

TransMedics Group, Inc. (TMDX)vs ›

$3.06B

24.67

25.99

67.50

Doximity, Inc. (DOCS)vs ›

$5.00B

16.68

24.25

34.48

48.47

Merit Medical Systems, Inc. (MMSI)vs ›

$5.40B

19.16

17.20

25.96

27.67

Hims & Hers Health, Inc. (HIMS)vs ›

$6.43B

25.05

28.20

36.75

93.81

Chemed Corporation (CHE)vs ›

$6.84B

18.02

15.04

21.48

22.84

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

PDSB Price/OCF Ratio Metrics

PDSB Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics